Filing Details

Accession Number:
0001225208-11-024090
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-11-01 16:39:14
Reporting Period:
2011-10-31
Filing Date:
2011-11-01
Accepted Time:
2011-11-01 16:39:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
14272 Bristol Myers Squibb Co BMY Pharmaceutical Preparations (2834) 220790350
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1198959 M James Cornelius Bristol-Myers Squibb Company
345 Park Avenue
New York NY 10154
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.10 Par Value Acquisiton 2011-10-31 440,188 $17.51 1,433,612 No 4 M Direct
Common Stock, $0.10 Par Value Disposition 2011-10-31 440,188 $31.87 993,424 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, $0.10 Par Value Executive Option (right to buy) Disposition 2011-10-31 440,188 $0.00 440,188 $17.51
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2019-03-02 No 4 M Direct
Footnotes
  1. The price reported reflects the weighted average sale price. These shares were sold in multiple transactions ranging from $31.7950 to $32.0500. The reporting person hereby undertakes to provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transactions were effected.
  2. As Mr. Cornelius had attained age 60, this stock option award vested 100% on March 3, 2010, the first anniversary of the grant date.